Compare American Well Corp (AMWL) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Newmont Corporation — how do they compare? American Well Corp trades at $10.74 (market cap $165.58M), while Newmont Corporation trades at $93.73 (market cap $101.73B). The key difference: Newmont Corporation is far larger — about 614.4× American Well Corp's market cap, and Newmont Corporation pays a 1.09% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | NEM | |
|---|---|---|
Market Cap | $165.58M | $101.73B |
Sector | Health | Basic Materials |
52-Week High | $9.91 | $131.95 |
52-Week Low | $3.78 | $57.35 |
Enterprise Value | -$9.66M | $98.48B |
Dividend Yield | — | 1.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Newmont Corporation (NEM) trades at $95.29, up 0.51% with bearish technical signals but strong fundamentals. The gold miner reported record Q1 2026 earnings of $2.90 EPS, beating estimates by 40%, with revenue growth accelerating to 46% year-over-year. Analyst consensus remains strongly bullish with 75% buy ratings and a $141 price target representing 48% upside. Cash flow generation reached $3.1 billion in Q1, supporting dividend payments and debt reduction.
Despite gold price volatility creating near-term pressure, Newmont's operational excellence and margin expansion support long-term value. The stock trades at attractive valuations (P/E 12.4x) with 34% net margins, though exposure to commodity cycles and recent technical weakness require careful risk management. The upcoming Q2 earnings on July 23 will be critical for confirming the growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
